4//SEC Filing
Hackman Jeffrey S. 4
Accession 0001415889-25-013673
CIK 0001211583other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:42 PM ET
Size
6.5 KB
Accession
0001415889-25-013673
Insider Transaction Report
Form 4
Hackman Jeffrey S.
DirectorChief Executive Officer
Transactions
- Purchase
Common Shares
2025-05-16$6.75/sh+1,035$6,986→ 1,035 total - Purchase
Common Shares
2025-05-19$6.99/sh+13,965$97,615→ 15,000 total
Footnotes (1)
- [F1]Transaction Code P - Open market or private purchase of non-derivative or derivative security
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001926254
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:42 PM ET
- Size
- 6.5 KB